Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Circassia Pharmaceuticals ( (GB:NIOX) ) has shared an announcement.
Niox Group PLC, a UK-based company, has announced a change in its shareholder structure, with Rathbones Investment Management Ltd adjusting its voting rights. As of June 23, 2025, Rathbones’ voting rights in Niox Group PLC decreased from 10.7058% to 8.6953%. This change reflects a strategic decision by Rathbones and may impact Niox Group’s shareholder dynamics and influence within the company.
The most recent analyst rating on (GB:NIOX) stock is a Buy with a £77.00 price target. To see the full list of analyst forecasts on Circassia Pharmaceuticals stock, see the GB:NIOX Stock Forecast page.
Spark’s Take on GB:NIOX Stock
According to Spark, TipRanks’ AI Analyst, GB:NIOX is a Neutral.
Circassia Pharmaceuticals (GB:NIOX) shows strength in financial performance with stable cash flow and revenue growth, which are major contributors to its score. The high corporate events score reflects strategic initiatives and positive sales momentum. However, the valuation presents concerns due to a high P/E ratio and an unusual dividend yield. Technical analysis suggests caution due to mixed indicators.
To see Spark’s full report on GB:NIOX stock, click here.
More about Circassia Pharmaceuticals
Average Trading Volume: 1,427,776
Technical Sentiment Signal: Buy
Current Market Cap: £267.1M
See more data about NIOX stock on TipRanks’ Stock Analysis page.